Tofacitinib is a Janus kinase inhibitor used to treat rheumatoid arthritis and ulcerative colitis. It works by blocking inflammatory pathways, reducing symptoms and disease activity. This medication is crucial for managing autoimmune conditions. In summary, Tofacitinib is effective in treating rheumatoid arthritis and ulcerative colitis.
Tofacitinib inhibits Janus kinases, disrupting signaling pathways involved in inflammation and immune responses.


















